Concave Pyridines for Bifunctional Acid–Base Catalysis
FULL PAPER
280 mg (98%) of 16. H NMR (500 MHz, CDCl3): δ = 7.67 (t, J
to yield 918 mg (98 %) of 14. 1H NMR (500 MHz, CDCl3/
1
CD3OD): δ = 7.79 (t, J = 7.7 Hz, 1 H, 4-H), 7.27, 7.26 (4 d, each = 7.7 Hz, 1 H, 4-H), 7.19 (t, J = 8.3 Hz, 1 H, 4ЈЈ-H), 7.17 (d, J =
J = 7.7 Hz, 2 H, 3-H, 5-H), 7.24 (t, J = 8.4 Hz, 1 H, 4Ј-H), 6.57 (s,
2 H, 3Ј-H, 5Ј-H), 6.56 (d, J = 8.4 Hz, 2 H, 3ЈЈ-H, 5ЈЈ-H), 5.36–5.27
7.7 Hz, 2 H, 3-H, 5-H), 6.57 (d, J = 8.3 Hz, 2 H, 3ЈЈ-H, 5ЈЈ-H), 6.54
(s, 2 H, 3Ј-H, 5Ј-H), 5.71, 5.70 (2 tdd, J = 6.7 Hz, J = 10.2 Hz, J
(m, 4 H, =CH, E/Z), 4.60 (s, 2 H, Ar-CH2-OH), 3.95–3.81 (m, 8 H, = 16.9 Hz, 4 H, CH=), 4.95–4.87 (m, 8 H, =CH2), 4.63 (s, 2 H, Ar-
OCH2), 1.98–1.80 (m, 8 H, CH2CH=), 1.70–1.60, 1.56–1.46 (2 m, CH2-O), 3.88–3.83 (m, 8 H, OCH2), 2.01–1.92, (m, 8 H, CH2CH=),
8 H, OCH2CH2) ppm. 13C NMR (125 MHz, CDCl3/CD3OD): δ = 1.64–1.54 (m, 8 H, OCH2CH2), 1.38–1.30 (m, 8 H, CH2) ppm. 13C
157.4 (s, C-2Ј, C-6Ј), 157.3 (s, C-2ЈЈ, C-6ЈЈ), 153.7 (s, C-2), 153.6 (s,
NMR (125 MHz, CDCl3): δ = 157.8 (2 s, C-2Ј, C-6Ј, C-2ЈЈ, C-6ЈЈ),
C-6), 142.9 (s, C-4Ј), 135.2 (d, C-4), 129.6 (d, =CH), 129.3 (d, C- 154.1 (s, C-2), 153.9 (s, C-6), 142.6 (s, C-4Ј), 138.7 (d, CH=), 134.7
4ЈЈ), 124.1, 124.0 (2 d, C-3, C-5), 118.9 (s, C-1Ј), 117.4 (s, C-1ЈЈ),
103.9 (d, C-3ЈЈ, C-5ЈЈ), 102.3 (d, C-3Ј, C-5Ј), 66.2 (t, OCH2), 64.8
(t, Ar-CH2-OH), 29.1 (t, CH2CH=), 22.9 (t, OCH2CH2) ppm. IR
(d, C-4), 128.9 (d, C-4ЈЈ), 123.8 (d, C-3, C-5), 121.1 (s, C-1ЈЈ), 120.1
(s, C-1Ј), 114.4 (t, =CH2), 105.7 (d, C-3ЈЈ, C-5ЈЈ), 103.9 (d, C-3Ј,
C-5Ј), 68.5 (t, OCH2), 65.4 (t, Ar-CH2-OH), 33.2 (t, CH2CH=),
(KBr): ν = 3405, 2928, 2856, 1598, 1458, 1432, 1102 cm–1. MS 28.5 (t, OCH CH ), 25.1 (t, CH ) ppm. IR (KBr): ν = 2937, 2865,
˜
˜
2
2
2
(ESI): m/z (%) = 564 (72) [M + Na]+, 542 (100) [M + H]+.
1639, 1598, 1458, 1431, 1249, 1121 cm–1. MS (ESI): m/z (%) = 654
(100) [M + H]+.
Methyl 3-({2,11,13,22-Tetraoxa-1,12(1,3,2)-dibenzena-23(2,6)-pyri-
dinabicyclo[10.10.1]tricosaphan-6,17-dien-15-yl}methyloxy)benzoate
(15): 15-(Hydroxymethyl)-2,11,13,22-tetraoxa-1,12(1,3,2)-di-
benzena-23(2,6)-pyridinabicyclo[10.10.1]tricosaphan-6,17-diene
(14, 332 mg, 612 µmol), methyl-3-hydroxybenzoate (94.0 mg,
614 µmol) and triphenylphosphane (204 mg, 776 µmol) were dis-
solved in tetrahydrofuran (20 mL). At 0 °C, diisopropyl azodicar-
boxylate (184 µL, 946 µmol) was added and the mixture was stirred
for 18 h at room temp. After addition of water (10 mL), the layers
were separated and the aqueous layer was extracted with diethyl
ether (3ϫ15 mL). The combined organic layer was washed with
brine (2ϫ15 mL) and dried with magnesium sulfate. The solvent
was evaporated in vacuo, and the residue was purified by column
chromatography (silica gel, cyclohexane/ethyl acetate, 3:1) and by
chromatography with a chromatotron (silica gel, cyclohexane/ethyl
acetate, 9:1 to 3:1) to yield 360 mg (87 %) of 15. 1H NMR
(600 MHz, CDCl3): δ = 7.73 (t, J = 7.7 Hz, 1 H, 4-H), 7.67–7.64
(m, 2 H, Ar-4-H, Ar-6-H), 7.35 (t, J = 7.9 Hz, 1 H, Ar-5-H), 7.20
(t, J = 8.3 Hz, 1 H, 4ЈЈ-H), 7.19 (2 d, J = 7.7 Hz, J = 7.7 Hz, 2 H,
3-H, 5-H), 7.17–7.15 (m, 1 H, Ar-2-H), 6.62 (s, 2 H, 3Ј-H, 5Ј-H),
6.55 (d, J = 8.3 Hz, 2 H, 3ЈЈ-H, 5ЈЈ-H), 5.36–5.30 (m, 4 H, =CH),
5.08 (s, 2 H, ArO-CH2), 3.91 (s, 3 H, Ar-COOCH3), 3.90–3.84 (m,
8 H, OCH2), 2.01–1.92, 1.89–1.81 (2 m, 8 H, CH2CH=), 1.66–1.58,
1.56–1.48 (2 m, 8 H, OCH2CH2) ppm. 13C NMR (125 MHz,
CDCl3): δ = 166.9 (s, ArCOOCH3), 158.7 (Ar-C-3), 157.7 (s, C-2Ј,
C-6Ј), 157.6 (s, C-2ЈЈ, C-6ЈЈ), 154.3 (s, C-2), 154.0 (s, C-6), 137.6 (s,
C-4Ј), 134.8 (d, C-4), 131.4 (s, Ar-C-1), 129.9, 129.8 (2 d, =CH),
129.5 (d, Ar-C-5), 128.9 (d, C-4ЈЈ), 123.8, 123.7 (2 d, C-3, C-5),
122.2 (d, Ar-C-6), 120.2 (d, Ar-C-2), 120.1 (s, C-1ЈЈ), 119.8 (s, C-
1Ј), 115.3 (d, Ar-C-4), 104.2 (d, C-3ЈЈ, C-5ЈЈ), 103.3 (d, C-3Ј, C-5Ј),
70.6 (t, ArO-CH2-), 66.6, 66.5 (2 t, OCH2), 52.2 (q, ArCOOCH3),
29.4, 29.3 (2 d, CH2CH=), 23.2, 23.1 (2 t, OCH2CH2-) ppm. IR
15-(Hydroxymethyl)-2,13,15,26-tetraoxa-1,14(1,3,2)-dibenzena-
27(2,6)-pyridinabicyclo[12.12.1]heptacosaphan-7,20-diene (17): Syn-
thesis according to the general procedure: Benzylidenebis(tricy-
clohexylphosphane)dichlororuthenium (41 mg, 50 µmol) and 2-
[2,6-bis(hex-5-enyloxy)phenyl]-6-[2,6-bis(hex-5-enyloxy)-4-(hy-
droxymethyl)phenyl]pyridine (16, 405 mg, 621 µmol). Purification:
column chromatography on silica gel eluting with cyclohexane/
ethyl acetate (1:3). Yield: 330 mg (89 %). 1H NMR (500 MHz,
CDCl3): δ = 7.69 (t, J = 7.7 Hz, 1 H, 4-H), 7.21 (t, J = 8.3 Hz, 1 H,
4Ј-H), 7.16, 7.12 (4 d, each J = 7.7 Hz, 2 H, 3-H, 5-H), 6.56 (d, J
= 8.4 Hz, 2 H, 3ЈЈ-H, 5ЈЈ-H), 6.44 (s, 2 H, 3Ј-H, 5Ј-H), 5.29–5.16
(m, 4 H, =CH, E/Z), 4.55 (3 s, 2 H, Ar-CH2-OH), 3.96–3.68 (m,
8 H, OCH2), 2.14–1.89 (m, 8 H, CH2CH=), 1.60–1.24 (m, 20 H,
CH2) ppm. 13C NMR (125 MHz, CDCl3/CD3OD): δ = 157.9 (s, C-
2Ј, C-6Ј), 157.7 (s, C-2ЈЈ, C-6ЈЈ), 154.4 (s, C-2), 154.3 (s, C-6), 143.3
(s, C-4Ј), 134.8 (d, C-4), 130.7 (d, =CH), 129.0 (d, C-4ЈЈ), 123.8,
123.7 (2 d, C-3, C-5), 120.2 (s, C-1Ј), 118.8 (s, C-1ЈЈ), 104.6 (d, C-
3ЈЈ, C-5ЈЈ), 102.6 (d, C-3Ј, C-5Ј), 68.7 (t, OCH2), 64.6 (t, Ar-CH2-
OH), 31.6 (t, CH2CH=), 27.6 (t, OCH2CH2), 26.6, 24.9 (3 t, CH2)
ppm. IR (KBr): ν = 2936, 1641, 1598, 1458, 1431, 1249, 1109 cm–1.
˜
MS (ESI): m/z (%) = 598 (100) [M + H]+.
15-(Hydroxymethyl)-2,13,15,26-tetraoxa-1,14(1,3,2)-dibenzena-
27(2,6)-pyridinabicyclo[12.12.1]heptacosaphane (18): Palladium on
charcoal (10%, 110 mg) was mixed with methanol (50 mL) and hy-
drogen gas was bubbled through the mixture for 30 min. This acti-
vated mixture was then mixed with a solution of 15-(hydroxy-
methyl)-2,13,15,26-tetraoxa-1,14(1,3,2)-dibenzena-27(2,6)-pyridina-
bicyclo[12.12.1]heptacosaphan-7,20-diene (17, 300 mg, 503 µmol)
in methanol/chloroform (1:1, 6 mL), and hydrogen gas was bubbled
through the solution for 3 h while stirring at room temperature was
continued. Stirring of the solution under an atmosphere of hydro-
gen was continued for 18 h at room temperature. The solvent was
evaporated in vacuo and the residue was purified by column
chromatography (silica gel, cyclohexane/ethyl acetate, 1:3) and by
chromatography with a chromatotron (silica gel, cyclohexane/ethyl
acetate, 1:1 to 1:3) to yield 290 mg (96 %) of 18. 1H NMR
(500 MHz, CDCl3): δ = 7.68 (t, J = 7.7 Hz, 1 H, 4-H), 7.20 (t, J =
8.3 Hz, 1 H, 4ЈЈ-H), 7.18, 7.16 (2 d, J = 7.7 Hz, 1 H, 3-H, 5-H),
6.56 (d, J = 8.3 Hz, 2 H, 3ЈЈ-H, 5ЈЈ-H), 6.46 (s, 2 H, 3Ј-H, 5Ј-H),
4.62 (s, 2 H, Ar-CH2-OH), 4.03–3.94, 3.90–3.81 (2 m, 8 H, OCH2),
1.62–1.50, 1.34–1.08 (m, 32 H, CH2) ppm. 13C NMR (125 MHz,
CDCl3): δ = 157.8 (s, C-2Ј, C-6Ј), 157.6 (s, C-2ЈЈ, C-6ЈЈ), 154.2 (s,
C-2), 154.1 (s, C-6), 143.2 (s, C-4Ј), 134.5 (d, C-4), 128.9 (d, C-4ЈЈ),
123.9 (d, C-3), 123.8 (d, C-5), 120.5 (s, C-1ЈЈ), 119.1 (s, C-1Ј), 104.9
(d, C-3ЈЈ, C-5ЈЈ), 103.1 (d, C-3Ј, C-5Ј), 68.5 (t, OCH2), 64.7 (t, Ar-
CH2-OH), 28.1 (t, OCH2CH2), 26.7, 25.7, 24.3 (3 t, CH2) ppm. IR
(KBr): ν = 2922, 2867, 1721, 1582, 1455, 1435, 1290, 1279, 1116,
˜
1103 cm–1. MS (ESI): m/z (%) = 698 (19) [M + Na]+, 676 (100) [M
+ H]+. C42H46NO7 (675.81): calcd. C 74.64, H 6.71, N 2.07; found
C 74.68, H 6.91, N 2.12.
2-[2,6-Bis(hex-5-enyloxy)phenyl]-6-[2,6-bis(hex-5-enyloxy)-4-(hy-
droxymethyl)phenyl]pyridine (16): A solution of p-toluenesulfonic
acid (100 mg, 525 µmol) in dry methanol (5 mL) was added drop-
wise over 5 min to a solution of 2-[2,6-bis(hex-5-enyloxy)phenyl]-6-
[2,6-bis(hex-5-enyloxy)-4-(2-tetrahydropyranyloxymethyl)phenyl]-
pyridine (12b, 321 mg, 437 µmol) heated to reflux in dry methanol
(20 mL). Heating was continued for 90 min. The volume was re-
duced to 5 mL. After the addition of saturated aqueous sodium
hydrogen carbonate (5 mL) and chloroform (20 mL), the water
layer was extracted with chloroform (3ϫ20 mL), and the combined
organic layers were washed with brine (15 mL). The solvent was
removed in vacuo, and the residue was purified by column
chromatography (silica gel, cyclohexane/ethyl acetate, 1:3) to yield
(KBr): ν = 3405, 2928, 2856, 1598, 1458, 1432, 1102 cm–1. MS
˜
Eur. J. Org. Chem. 2007, 972–980
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
979